SERI SURGICAL SCAFFOLD SCF10X25AGEN 94675

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer report with the FDA on 2017-08-18 for SERI SURGICAL SCAFFOLD SCF10X25AGEN 94675 manufactured by Sofregen, Inc.

Event Text Entries

[83058553]
Patient Sequence No: 1, Text Type: N, H10


[83058554] On (b)(6) 2017, a case was received from the fda (report number: mw5070605). It reported the following: surgery to include seri mesh scaffold (allergan manufactured) since now they have sold to sofregen medical, since initial install on (b)(6) 2015-leading to infection which has resulted in (continued) multiple surgeries to remove, efforts to correct damaging effects from the medical device and long term antibiotics. On (b)(6) 2017, the reporter was called and a message was left requesting additional information. On (b)(6) 2017, the reporter called and stated she had thick case file regarding the issues she has experienced. She is willing to share the information with sofregen and will email the information she is willing to share. On (b)(6) 2017 she shared the following information. Procedure date: (b)(6) 2015: operations performed: abdominal wall reinforcement with 10 x 15 cm biological mesh, bilateral implantable doppler placement, and multilevel intercostal nerve blockade with 20 mg of liposomal bupivacaine of chest and abdomen for postoperative analgesia. The findings from these procedures as they pertain to seri are as follows: attention was then turned to closing the abdomen. The abdominal fascia was closed in a layered fashion using a ethibond suture. One piece of 10 x25 cm biological mesh was then overlaid over the fascial repair and inset using 0 ethibond sutures. The patient was then flexed in a beach-chair position. The superior abdominal flap was then tailor tacked to the lower abdominal flap and the umbilicus was inset through a separate chevron incision using 4-6 monocryl and 5-0 prolene sutures. The umbilicus was pink and viable at the completion of the inset. The abdomen was then closed in a layered fashion using #2 quill pdo sutures to close the scarpa fascia, followed by 3-0 pds v-loc sutures in the subticular plane. Two 19-french round drains were placed in the abdomen through separate stab incisions and anchored to the skin using 2-0 prolene sutures. (continued on page 4)
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8020862-2017-00011
MDR Report Key6804910
Report SourceCONSUMER
Date Received2017-08-18
Date of Report2017-08-18
Date of Event2015-10-02
Date Mfgr Received2017-07-19
Date Added to Maude2017-08-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer Street200 BOSTON AVE. SUITE 1100
Manufacturer CityMEDFORD MA 021554288
Manufacturer CountryUS
Manufacturer Postal021554288
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSERI SURGICAL SCAFFOLD
Generic NameSERI SURGICAL SCAFFOLD
Product CodeOXF
Date Received2017-08-18
Model NumberSCF10X25AGEN
Catalog Number94675
Lot NumberP14091501A
Device Expiration Date2017-10-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSOFREGEN, INC
Manufacturer AddressUS


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2017-08-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.